2 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 3 Phase 2, 2 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
| Phase 3 | 2 | Unknown 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Anti-Inflammatory Agents: new trials by email Literature Review of Anti-Inflammatory Agents trials Research Report on Anti-Inflammatory Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inflammation's Impact on Heart Disease and Diabetes Gastric bypass - Inflammation, Obesity and Type 2 Diabetes | Recruiting | University of Aarhus | 250 | 2025-01-30 | 2025-02-03 | |
| Anakinra in Dengue With Hyperinflammation ( AnaDen ) Placebo, Anakinra - Dengue, Dengue With Warning Signs | Phase 2 | Active not recruiting | Oxford University Clinical Research Unit, Vietnam | 160 | 2023-01-02 | 2026-01-06 |
| Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression VTS-K - Treatment Resistant Depression, Major Depressive Disorder | Phase 4 | Completed | Theresa Jacob, PhD, MPH | 15 | 2022-12-06 | 2026-04-21 |
| The ALA, DHA and EPA Esters in the Prevention of Cardiovascular Diseases. Fatty Acids, Unsaturated, Diagnostic Tests - Fatty Acids, Alpha-Linolenic Acid | Phase 3 | Unknown | Wroclaw Medical University | 200 | 2020-12-09 | 2021-02-08 |
| Metformin in Dengue With Obesity Metformin - Dengue, Viral Infection | Phase 1 / Phase 2 | Completed | Oxford University Clinical Research Unit, Vietnam | 120 | 2020-07-27 | 2023-08-31 |
| Anti-inflammatory Treatment for Inactive Takayasu Arteritis Prednisone, cyclophosphamide - Takayasu Arteritis, Anti-Inflammatory Agents | Phase 2 / Phase 3 | Unknown | Chinese Academy of Medical Sciences, Fuwai Hospital | 40 | 2018-06-01 | 2018-06-08 |
Dengue (2) · Obesity (2) · Overweight (2) · Agnosia (1) · Body Weight (1) · Cardiovascular Diseases (1) · Cytokine Release Syndrome (1) · Depression (1) · Depressive Disorder, Major (1) · Depressive Disorder, Treatment-Resistant (1) · Diabetes Mellitus, Type 2 (1) · Disease (1) · Inflammation (1) · Insulin Resistance (1) · Macrophage Activation Syndrome (1)
Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (3) · Arbovirus Infections (2) · Flaviviridae Infections (2) · Flavivirus Infections (2) · Hemorrhagic Fevers, Viral (2) · Infections (2) · Mosquito-Borne Diseases (2) · Nutrition Disorders (2) · Nutritional and Metabolic Diseases (2) · Pathologic Processes (2) · RNA Virus Infections (2) · Vector Borne Diseases (2) · Aortic Arch Syndromes (1) · Aortic Diseases (1)
Aspirin (1) · Cyclophosphamide (1) · Diagnostic Tests, Routine (1) · Fatty Acids, Unsaturated (1) · Gastric Bypass (1) · Interleukin 1 Receptor Antagonist Protein (1) · Ketamine (1) · Metformin (1) · Prednisone (1)
Oxford University Clinical Research Unit, Vietnam (2) · Chinese Academy of Medical Sciences, Fuwai Hospital (1) · Theresa Jacob, PhD, MPH (1) · University of Aarhus (1) · Wroclaw Medical University (1)
Vietnam (2) · Denmark (1) · Poland (1) · United States (1)
Maria M Bujnowska-Fedak, MD, PhD (1) · Sophie Yacoub (1) · Sophie Yacoub, PhD. MD (1) · Theresa Jacob, PhD, MPH (1) · Xiongjing Jiang, MD (1)